Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
438.00    -1.80 (-0.41%)
Bid:
440.20
Ask:
441.00
Spread: 0.80 (0.182%)
Market Cap: £2.25b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

Total Voting Rights

30 Jun 2025 16:00

RNS Number : 0389P
QinetiQ Group plc
30 June 2025
 

QinetiQ Group plc

Total Voting Rights

 

30 June 2025 - In accordance with the Financial Conduct Authority's (FCA) Disclosure Guidance and Transparency Rule 5.6.1R, QinetiQ Group plc ("the Company") notifies the market that as of 30 June 2025 the Company's issued ordinary share capital consists of 544,327,145 ordinary shares of one penny each. There are no shares held in treasury. 

Therefore, the total number of voting rights in the Company is 544,327,145. This figure may be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

About QinetiQ:

QinetiQ is an integrated global defence and security company focused on mission-led innovation. QinetiQ employs circa 8,500 highly-skilled people, committed to creating new ways of protecting what matters most; testing technologies, systems, and processes to make sure they meet operational needs; and enabling customers to deploy new and enhanced capabilities with the assurance they will deliver the performance required.

 

For further information, please contact:

Stephen Lamacraft, Interim Group Investor Relations Director:

+44 (0) 7920 545841

Stephanie Mann, Group Head of Media Relations:

+44 (0) 7770 720268

James Field, Company Secretary:

+44 (0) 7841 662957

 

QinetiQ Group plc LEI: 213800S8OBDOZMCMUW34

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRBSGDLBXXDGUG
Date   Source Headline
23rd May 20197:00 amRNSPreliminary Results
10th May 201910:47 amRNSDirector/PDMR Shareholding
1st May 20191:41 pmRNSBlock listing Interim Review
10th Apr 20193:29 pmRNSDirector/PDMR Shareholding
10th Apr 20197:00 amRNSQinetiQ completes pension scheme buy-in
5th Apr 20191:13 pmRNSQinetiQ secures £1.3bn LTPA amendment
28th Mar 20194:20 pmRNSUpdate on LTPA amendment
21st Mar 20197:00 amRNSDirectorate Change
15th Mar 20197:00 amRNSQinetiQ North America Wins U.S. Army CRS contract
14th Mar 20191:06 pmRNSUS robotics contract update
12th Mar 20191:52 pmRNSDirector/PDMR Shareholding
12th Feb 201911:59 amRNSDirector/PDMR Shareholding
11th Feb 20199:18 amRNSDirector/PDMR Shareholding
31st Jan 20197:00 amRNSThird Quarter Trading Update
10th Jan 201912:02 pmRNSDirector/PDMR Shareholding
31st Dec 201812:58 pmRNSHolding(s) in Company
31st Dec 201812:56 pmRNSHolding(s) in Company
31st Dec 201812:50 pmRNSHolding(s) in Company
21st Dec 20184:36 pmRNSHolding(s) in Company
12th Dec 20189:20 amRNSHolding(s) in Company
11th Dec 20182:00 pmRNSDirector/PDMR Shareholding
30th Nov 201810:40 amRNSHolding(s) in Company
20th Nov 201810:00 amRNSQinetiQ completes strategic investment in Inzpire
15th Nov 20187:00 amRNSInterim Results
12th Nov 20184:10 pmRNSDirector/PDMR Shareholding
6th Nov 20181:33 pmRNSBlock listing Interim Review
22nd Oct 20187:00 amRNSStrategic investment in Inzpire
18th Oct 20187:00 amRNSAcquisition of E.I.S. Aircraft Operations
15th Oct 20181:51 pmRNSHolding(s) in Company
10th Oct 20183:56 pmRNSDirector/PDMR Shareholding
10th Oct 20189:00 amRNSAurora Partnership
13th Sep 20187:00 amRNSInvestor teach-in
11th Sep 20181:33 pmRNSDirector/PDMR Shareholding
3rd Sep 20182:13 pmRNSDirector/PDMR Shareholding
10th Aug 20181:00 pmRNSDirector/PDMR Shareholding
1st Aug 20187:00 amRNSTotal Voting Rights
25th Jul 201812:27 pmRNSResult of AGM
25th Jul 20187:00 amRNSFirst Quarter Trading Update
10th Jul 201811:24 amRNSDirector/PDMR Shareholding
2nd Jul 20187:00 amRNSTotal Voting Rights
22nd Jun 20182:10 pmRNSDirector/PDMR Shareholding
13th Jun 201811:36 amRNSAnnual Financial Report
13th Jun 20187:55 amRNSHolding(s) in Company
12th Jun 20185:19 pmRNSDirector/PDMR Shareholding
12th Jun 201812:09 pmRNSDirector/PDMR Shareholding
24th May 201812:02 pmRNSHolding(s) in Company
24th May 20187:00 amRNSFull Year Results 2018
10th May 201812:24 pmRNSDirector/PDMR Shareholding
1st May 20188:01 amRNSBlock listing Interim Review
24th Apr 20187:00 amRNSAcquisition of E.I.S. Aircraft Operations

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.